Content about European Commission

November 5, 2012
Watson-Actavis latest among generic M&As

In what its president and CEO called a “significant milestone,” Watson Pharmaceuticals announced last month that the U.S. Federal Trade Commission and European Commission had approved its acquisition of Swiss generic drug maker Actavis.

In what its president and CEO called a “significant milestone,” Watson Pharmaceuticals announced last month that the U.S. Federal Trade Commission and European Commission had approved its acquisition of Swiss generic drug maker Actavis. Watson announced the $5.6 billion acquisition of Actavis in April, a deal that is expected to make Watson the third-largest generic drug maker in the world, after Teva Pharmaceutical Industries and Mylan.

October 8, 2012
European Commission approves Watson-Actavis merger

European regulators have approved U.S. drug maker Watson's acquisition of Switzerland-based Actavis, Watson said.

PARSIPPANY, N.J. — European regulators have approved U.S. drug maker Watson's acquisition of Switzerland-based Actavis, Watson said.

Watson said the European Commission had approved its $5.6 billion purchase of the drug maker, formerly based in Iceland, which Watson announced in April 2012.

Watson expects the transaction to be finished by the end of this year, subject to regulatory approval by the Federal Trade Commission. The acquisition is expected to create the world's third-largest generic drug maker.

March 26, 2012
ReportersNotebook — Beauty Care, 4/2/12

The Cosmetic Ingredient 
Review, an independent panel of scientific and medical experts, reaffirmed at its recent public meeting that parabens — a family of preservatives used in cosmetics and personal care products — are safe, the Personal Care Products Council has announced.

SUPPLIER NEWS — The Cosmetic Ingredient 
Review, an independent panel of scientific and medical experts, reaffirmed at its recent public meeting that parabens — a family of preservatives used in cosmetics and personal care products — are safe, the Personal Care Products Council has announced. At its 2012 meeting in early March, CIR reviewed the European Commission’s Scientific Committee on Consumer Safety’s opinions and concluded that there was little additional new data concerning parabens.

November 16, 2010
European Commission OKs sale of Sara Lee beauty, detergent businesses to Unilever

The European Commission has approved the sale of Sara Lee's global body care and European...

DOWNERS GROVE, Ill. — The European Commission has approved the sale of Sara Lee's global body care and European detergent businesses to Unilever, provided that Unilever divest the Sanex brand of bath and body products in the European market after it acquires the business from Sara Lee.

The global body care and European detergent businesses encompass such brands as Sanex, Radox and Duschdas. The transaction was originally announced in September.